Insiders · Profile

Jeanmonod Patrik

Chief Financial Officer at Cytek Biosciences. Filing since 1 Aug 2022. CIK 0001873085

Company
Date
Role
Action
Shares
Amount
Of holding
26 Dec 2023
Chief Financial Officer
Sold on a plan
3,000
$28.50K
3.1%
24 Nov 2023
Chief Financial Officer
Sold at will
3,000
$20.82K
3.0%
24 Oct 2023
Chief Financial Officer
Sold on a plan
3,000
$14.04K
3.0%
25 Sep 2023
Chief Financial Officer
Sold on a plan
3,000
$19.14K
2.9%
24 Aug 2023
Chief Financial Officer
Sold on a plan
3,000
$23.07K
2.9%
24 Jul 2023
Chief Financial Officer
Bought on a plan
3,000
$27.51K
3.0%
26 Jun 2023
Chief Financial Officer
Sold at will
3,000
$23.88K
2.8%
24 May 2023
Chief Financial Officer
Sold on a plan
3,000
$23.28K
2.7%
24 Apr 2023
Chief Financial Officer
Sold on a plan
3,000
$30.72K
2.7%
24 Mar 2023
Chief Financial Officer
Sold at will
3,000
$24.99K
2.6%
24 Feb 2023
Chief Financial Officer
Sold, plan not stated
3,000
$33.15K
2.6%
24 Jan 2023
Chief Financial Officer
Sold, plan not stated
3,500
$38.68K
4.4%
27 Dec 2022
Chief Financial Officer
Sold, plan not stated
3,500
$34.20K
4.2%
25 Nov 2022
Chief Financial Officer
Sold, plan not stated
3,500
$50.05K
4.0%
24 Oct 2022
Chief Financial Officer
Sold, plan not stated
3,500
$53.06K
3.9%
26 Sep 2022
Chief Financial Officer
Sold, plan not stated
3,500
$44.21K
3.8%
24 Aug 2022
Chief Financial Officer
Sold, plan not stated
3,500
$47.08K
3.6%
1 Aug 2022
Chief Financial Officer
Sold, plan not stated
3,500
$44.80K
3.6%
18 decisions on file.